BMS statement – HRT prescribing
The Daily Telegraph and the Sun published articles on Monday 19 December, relating to the prescribing of higher than licensed doses of oestrogen in HRT. The British Menopause Society is aware [...]
If you didn't find what you were looking for, try a new search!
The Daily Telegraph and the Sun published articles on Monday 19 December, relating to the prescribing of higher than licensed doses of oestrogen in HRT. The British Menopause Society is aware [...]
The BMS very much welcomes the recommendations of the Head of the HRT Taskforce Madelaine McTernan to the Department of Health and Social Care for future management of hormone [...]
From September women in the UK will be able to access Gina 10 microgram vaginal tablets without requiring a prescription For the first time ever in the UK, postmenopausal [...]
An editorial Looking at HRT in perspective - Helping women make informed choices by Haitham Hamoda and Sara Moger, was published today in the BMJ.
The BMS, FSRH, RCGP and RCOG have released a position statement on the supply shortages of Hormone Replacement Therapy (HRT) To read the full statement please click here
For a balanced and authoritative 6 minute summary of the current situation concerning HRT shortages and testosterone for women, listen to Dr Paula Briggs, Chair Elect of the British Menopause [...]
Serious Shortage Protocols (SSPs) issued to limit dispensing to 3 months’ supply of Oestrogel®, Ovestin® cream and Premique Low Dose® to ensure women across the UK will be able to [...]
The British Menopause Society very much welcomes the appointment of Madelaine McTernan CB, the Vaccine Taskforce Director General, as head of the new HRT Supply Taskforce. The HRT shortages have [...]
The British Menopause Society issues regular updates on HRT supply to provide guidance to BMS members and clinical practitioners on the current availability of HRT products. Full details on the [...]
The British Menopause Society has issued this further update on HRT product availability to provide guidance to BMS members and clinical practitioners on the current availability of HRT products. The update shows [...]